Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. - Cozzi,R.; Montini,M.; Attanasio,R.; Albizzi,M.; Lasio,G.; Lodrini,S.; Doneda,P.; Cortesi,L.; Pagani,G. (J Clin Endocrinol Metab, 2006)